Adam Feuerstein, Matthew Herper, and Angus Chen

BioTech

ASCO Takeaways: Winners, snoozers, the China question, and the art of cancer care

You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American Society of Clinical Oncology annual meeting. We’ll resume for ASCO

Adam Feuerstein, Matthew Herper, and Angus Chen June 4, 2024

BioTech

ASCO Daily Recap: AstraZeneca’s hat trick, a GSK turnaround, and palliative care as telehealth

You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American Society of Clinical Oncology annual meeting. Sign up here. CHICAGO

Adam Feuerstein, Matthew Herper, and Angus Chen June 2, 2024

BioTech

ASCO Daily Recap: Safety data for Novartis myelofibrosis candidate, survival data for Pfizer drug

You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American Society of Clinical Oncology annual meeting. Sign up here. CHICAGO

Adam Feuerstein, Matthew Herper, and Angus Chen June 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

Adam Feuerstein, Matthew Herper, and Angus Chen

ASCO Takeaways: Winners, snoozers, the China question, and the art of cancer care

ASCO Daily Recap: AstraZeneca’s hat trick, a GSK turnaround, and palliative care as telehealth

ASCO Daily Recap: Safety data for Novartis myelofibrosis candidate, survival data for Pfizer drug

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

Subscribe